Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Boykin, ChristiZhang, G.Chen, Yan-HuaZhang, R-WFan, X-EYang, W-MLu, Q.2016-05-242016-05-242011-03British Journal of Cancer; 104:5 p. 781-7890007-0920http://hdl.handle.net/10342/5298Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylationArticlepmc304820610.1038/bjc.2011.10